Delivery Order SPE2DB22D3016-SPE2DB24FALE8
Award Date
2/1/24
Potential Completion Date
2/2/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The $53,889.29 contract has an ultimate completion date of March 18, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract with DLA that serves as the primary vehicle for the company to deliver...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,265.40 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. This order is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product and has an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,583.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a ceiling value of $2,809.73 and a performance period ending on March 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The award is valued at $1,351.89 and has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a completion date of March 7, 2024 and a potential value of $7,079.93. This delivery order is issued under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that runs through December 31, 2025, which...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a ceiling value of $2,723.48 and a period of performance through April 2, 2024. Amerisourcebergen Drug Corp is a prime contractor for DLA Troop Support Medical, providing a wide range of pharmaceutical products and medical supplies to support military treatment...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,530.80 firm fixed price delivery order contract to provide BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This award is part of a larger $999,999,999.00 indefinite delivery contract between DLA and Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order...
The U.S. Defense Logistics Agency (DLA) awarded a $33,555.84 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a potential value of $12,697.79 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger indefinite delivery...